Nutra Pharma Corp. (OTCMKTS:NPHC) a BioTech in Multi Billion Dollar Pet Care Business

Nutra Pharma Corp. (OTCMKTS:NPHC) a BioTech in Multi Billion Dollar Pet Care Business

Millions of pets suffer from acute or chronic pain. While acute pain is a normal sensation triggered in the nervous system to alert your pet of possible injury and the need to take it easy, chronic pain is different, chronic pain persists. Pain signals keep firing in the nervous system for weeks, months, even years.

Pet Pain Away provides all-natural anti-inflammatory analgesic pain relief that is non-toxic, non-narcotic, non-steroidal and contains no aspirin or acetaminophen. Safe to use on pets, it treats conditions that cause chronic pain in animals.

Pet Pain Away is 100% Safe to Treat Your Pets Pain
Pet Pain Away works by targeting receptors on nerve cells. These receptors are found in nerves outside the central nervous system (brain and spinal cord) and they are also found on cells of the immune system. Specialized proteins in Pet Pain Away block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off. In clinical studies, the pain relieving ingredients in Pet Pain Away provided prolonged chronic muscle and joint relief.

petpainaway-dog-diagram

How do you Know When your Pet is Suffering from Pain
Here are some of the signs that your pet may be suffering from some type of chronic pain.

Changes to normal behaviors such as decreased ambulation or activity, lethargic attitude, decreased appetite, decreased self-grooming (cats).

Expressions of abnormal behaviors such as inappropriate elimination, vocalization, aggression, decreased interaction with other pets or family members, altered facial expressions, altered posture, restlessness, hiding (especially in cats).

Reaction to touch such as increased body tension or flinching in response to gentle palpation of the injured area and palpation of regions likely to be painful, e.g., neck, back, hips, elbows (cats).

Physiologic parameters like elevations in heart rate, respiratory rate, body temperature, and blood pressure or pupil dilation.

Current Medical Research of the Available Remedies
Current pain relief products for pets such as NSAIDs (just for dogs) such as Carprofen (Novox or Rimadyl), Deracoxib (Deramaxx), Etodolac (Etogesic), Firocoxib (Previcox), Meloxicam (Metacam ) or Tepoxalin ( Zubrin) have been shown to cause kidney, liver, or digestive problems. Cats do not tolerate NSAIDs of any kind well. The only approved NSAID for cats in the United States is meloxicam and it is only approved for a single post-surgical injection to relieve pain. The dose must be exactly correct for the cat’s weight. If it is given longer to cats, it often causes severe kidney damage.

Other Medications such as Amantadine, Gabapentin and Tramadol may cause upset stomach, decreased heart rate, panting, and constipation. Veterinarians may prescribe stronger opiates only for a short periods. They usually don’t prescribe steroids for pain, as they can have serious side effects. Veterinarians are usually hesitant to utilize pain therapies in companion animals because of the following: significant side effects, including nausea, vomiting, drowsiness, itching, constipation and respiratory depression; buildup of tolerance to analgesic requiring higher dosage over time to experience same effect; addictive properties that include severe withdrawal symptoms.

Today, cobra venom is successfully being used for treating various forms of pain, autoimmune and neurological disorders. The Nutra Pharma subsidiary, ReceptoPharm, and other researchers have definitively proven that extracts from cobra venom contain constituents that control pain and inflammation in animals.

The following two tabs change content below.
Shayne Heffernan Funds Manager at HEFFX holds a Ph.D. in Economics and brings with him over 25 years of trading experience in Asia and hands on experience in Venture Capital, he has been involved in several start ups that have seen market capitalization over $500m and 1 that reach a peak market cap of $15b. He has managed and overseen start ups in Mining, Shipping, Technology and Financial Services.

Latest posts by Shayne Heffernan (see all)

You must be logged in to post comments :  
CONNECT WITH